S. Abbott

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

Brad J. Wood, M. Proschan, A. Fauci, 2015, The Lancet.

What Are We Waiting for?-Start Screening High-risk Individuals for Anal Cancer Now-Reply.

J. Arnold, S. Abbott, A. Monroe, 2021, JAMA dermatology.

Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial.

M. Proschan, M. Polis, H. Masur, 2015, Annals of internal medicine.

The Risk of Anal Carcinoma After Anogenital Warts in Adults Living With HIV.

J. Arnold, S. Abbott, A. Monroe, 2021, JAMA dermatology.

Integrase Strand Transfer Inhibitors and Weight Gain in Children and Youth With Perinatal Human Immunodeficiency Virus in the DC Cohort

H. Masur, C. Dieffenbach, M. Horberg, 2021, Open forum infectious diseases.